From custom peptide synthesis to pharmaceutical-grade compounds — Helix Therapeutics delivers precision chemistry with rigorous quality control for researchers and biotech companies worldwide.
Helix Therapeutics was founded with a clear mission: to make high-quality peptides accessible to researchers and pharmaceutical companies without compromising on precision or purity.
Our team of PhD-level chemists and biochemists brings decades of hands-on experience in solid-phase peptide synthesis (SPPS), enabling us to tackle complex sequences, modified amino acids, and challenging large-scale productions.
Our state-of-the-art synthesis platforms and analytical technologies ensure every peptide meets the highest standards of purity and biological activity.
Advanced solid-phase peptide synthesis using both Fmoc and Boc chemistries, enabling the production of peptides from 2 to 100+ amino acid residues with exceptional efficiency.
Reverse-phase and ion-exchange HPLC systems achieving purity levels from 85% to >99%, verified by analytical HPLC and confirmed by mass spectrometry (ESI-MS / MALDI).
Comprehensive QC protocols including amino acid analysis, peptide content determination, moisture analysis, and bioburden testing for pharmaceutical-grade products.
Extensive portfolio of non-natural amino acids, stable isotope labeling, PEGylation, fluorescent labeling, and other chemical modifications for specialized research.
Seamless transition from milligram research quantities to multi-gram and kilogram-scale synthesis, maintaining consistent quality across all production volumes.
Lyophilized peptides shipped in validated cold-chain packaging with temperature monitoring to ensure product integrity from our facility to your lab.
From pharmaceutical-grade APIs to specialty cosmetic peptides, our catalog covers the full spectrum of peptide synthesis applications.
Stay informed on the latest developments in peptide science, industry news, and Helix Therapeutics company announcements.
Our Boston facility has completed the installation of a new automated peptide synthesizer, increasing our GMP production capacity by 300% to meet growing pharmaceutical demand.
Read MoreThe explosive growth of GLP-1 peptide therapeutics is creating unprecedented demand for large-scale SPPS. Our experts share insights on overcoming key synthesis hurdles.
Read MoreFollowing a comprehensive audit of our quality management systems, Helix Therapeutics has received recertification under ISO 9001:2015, reinforcing our commitment to excellence.
Read MoreOur scientific team is ready to help you find the right peptide solution. Whether it's a catalog compound or complex custom synthesis, we deliver.
Fill out the form below and a member of our scientific or commercial team will respond within one business day.
Reach us through any of the following channels. We aim to respond to all inquiries within one business day.